DE2945788A1 - Arzneimittel und seine verwendung - Google Patents

Arzneimittel und seine verwendung

Info

Publication number
DE2945788A1
DE2945788A1 DE19792945788 DE2945788A DE2945788A1 DE 2945788 A1 DE2945788 A1 DE 2945788A1 DE 19792945788 DE19792945788 DE 19792945788 DE 2945788 A DE2945788 A DE 2945788A DE 2945788 A1 DE2945788 A1 DE 2945788A1
Authority
DE
Germany
Prior art keywords
adjuvant
compound
antigen
immune substance
blood cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19792945788
Other languages
German (de)
English (en)
Other versions
DE2945788C2 (https=
Inventor
George Robert Sparta N.J. Hemsworth
Keith Edwin Waterford Conn. Jensen
John Shearer River Vale N.J. Wolff III
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE2945788A1 publication Critical patent/DE2945788A1/de
Application granted granted Critical
Publication of DE2945788C2 publication Critical patent/DE2945788C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
DE19792945788 1979-10-26 1979-11-13 Arzneimittel und seine verwendung Granted DE2945788A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/088,638 US4310550A (en) 1979-10-26 1979-10-26 Lipid amines formulated with fat or lipid emulsions as vaccine adjuvants

Publications (2)

Publication Number Publication Date
DE2945788A1 true DE2945788A1 (de) 1981-05-07
DE2945788C2 DE2945788C2 (https=) 1988-01-28

Family

ID=22212534

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19792945788 Granted DE2945788A1 (de) 1979-10-26 1979-11-13 Arzneimittel und seine verwendung

Country Status (7)

Country Link
US (1) US4310550A (https=)
JP (1) JPS5671024A (https=)
AU (1) AU522338B2 (https=)
CA (1) CA1163562A (https=)
DE (1) DE2945788A1 (https=)
NZ (1) NZ195354A (https=)
PT (1) PT71236A (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0058021A3 (en) * 1981-02-06 1982-10-27 Beecham Group Plc Pharmaceutical compositions
IL74289A (en) * 1985-02-10 1989-02-28 Israel State Vaccine system comprising a live-non-virulent vaccine and an adjuvant
NL9000207A (https=) * 1990-01-29 1991-08-16 Duphar Int Res
US6369201B1 (en) 1998-02-19 2002-04-09 Metamorphix International, Inc. Myostatin multimers
AU2002218927B2 (en) 2001-01-04 2007-08-30 The University Of British Columbia Enterohemorrhagic Escherichia coli vaccine
BRPI0415816A (pt) 2003-10-31 2006-12-26 Univ British Columbia composição, bactéria ou um preparado da mesma, método para detectar a presença de um patógeno de a/e em uma amostra, método para provocar uma resposta imunológica contra um patógeno de a/e ou um componente do mesmo em um animal, método para reduzir a colonização de um patógeno de a/e em um animal, método para reduzir a disseminação de um patógeno de a/e em um animal, método para o tratamento ou a prevenção da infecção por um patógeno de a/e, método para atenuar a virulência de um patógeno de a/e, método para a seleção de um composto que atenue a virulência de um patógeno e a/e, método para a produção de um polipeptìdio de patógeno de a/e, polipeptìdio recombinante, molécula de ácido nucléico isolada, vetor, célula hospedeira, uso da composição e kit
AU2005230708B2 (en) 2004-04-05 2009-01-15 Zoetis Services Llc Microfluidized oil-in-water emulsions and vaccine compositions
US20080102067A1 (en) * 2006-10-25 2008-05-01 Cook Mark E Immunogenic composition
WO2017011918A1 (en) 2015-07-22 2017-01-26 University Of Saskatchewan Mycoplasma bovis vaccines and uses thereof
CA3176303A1 (en) 2020-04-20 2021-10-28 Antonio FACCIUOLO Compositions and methods for preventing, controlling and diagnosing mycobacterial infections

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3872171A (en) * 1971-05-24 1975-03-18 Pfizer Polyamines as antiviral agents in animals
US4034040A (en) * 1971-05-24 1977-07-05 Pfizer Inc. Xylene-diamines as antiviral agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA725596A (en) * 1960-08-26 1966-01-11 J. Wretlind Arvid Method of preparing intravenously injectable fat emulsions free from side reactions or complications
US4173641A (en) * 1978-05-15 1979-11-06 Pfizer Inc. Di-O-n-alkyl glycerol derivatives as immune stimulants

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3872171A (en) * 1971-05-24 1975-03-18 Pfizer Polyamines as antiviral agents in animals
US4034040A (en) * 1971-05-24 1977-07-05 Pfizer Inc. Xylene-diamines as antiviral agents

Also Published As

Publication number Publication date
CA1163562A (en) 1984-03-13
JPS6225646B2 (https=) 1987-06-04
US4310550A (en) 1982-01-12
NZ195354A (en) 1982-12-21
AU6366480A (en) 1981-04-30
JPS5671024A (en) 1981-06-13
AU522338B2 (en) 1982-05-27
PT71236A (en) 1980-06-01
DE2945788C2 (https=) 1988-01-28

Similar Documents

Publication Publication Date Title
DE69304521T2 (de) Impfstoff Adjuvans
DE69937343T2 (de) Adjuvanszusammensetzung und methoden zu deren verwendung
DE69434956T2 (de) Auf einer Emusion und MPL basierte Adjuvantien für Impfstoffe
DE69724970T2 (de) Verfahren zur behandlung von hypersensitivität typ i unter verwendung von monophosphoryl-lipid a
DE60110822T2 (de) Zubereitung zur immunisierung gegen den aids-virus
DE69826842T2 (de) Wässerige immunologische adjuvantzusammensetzungen aus monophosphoryllipid a
DE69605296T3 (de) Impfstoffe die ein saponin und ein sterol enthalten
DE3712767C2 (https=)
DE68927679T2 (de) Immunhilfsmittel aus Liposome enthaltend Lymphokin IL -2
DE69934179T2 (de) Zusammensetzung enthaltend ein Antigen, ein TH-1 induzierendes Adjuvans und eine im Wasser schwer lösliche Aminosäure zur Verwendung in der Immunisierung
EP1144001A2 (de) Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation
DE3911442A1 (de) Impfstoff-praeparation
DE2736223A1 (de) Allergen enthaltende substanzen, verfahren zu ihrer herstellung und ihre verwendung
EP1113816A2 (de) Influenzavirus-impfstoffzusammensetzung
DE2606118A1 (de) Gamma-globuline fuer intravenoese injektion und verfahren zur herstellung von solchem gamma-globulin
DE69623072T2 (de) Impfstoffzusammensetzung für Säugetiere enthaltend Squalen oder Squalan, Phospholipid und ein Tensid als Adjuvans
DE69127694T2 (de) Herstellung und verwendung von transfer-faktor
DE68922109T2 (de) Gamma-inulin-zusammensetzungen.
DE19511276C2 (de) Adjuvans auf der Basis kolloidaler Eisenverbindungen
DE2603321A1 (de) Emulsion auf der grundlage eines stoffwechselfaehigen pflanzlichen oels und wasser
DE2945788A1 (de) Arzneimittel und seine verwendung
EP0363835A1 (de) Verwendung von Zink- oder Eisenhydroxid zur Adjuvierung von Antigenlösungen und auf diese Weise adjuvierte Antigenlösungen
DE69813070T2 (de) Pharmazeutische Zubereitung zur oralen Anwendung enthaltend einen Histamin-Immunoglobulin Komplex
DE1924304C3 (de) Diäthylaminoäthyldextran (DEAE-D) als Adjuvans für Impfstoffe zur aktiven Immunisierung von Säugetieren
EP0445710B1 (de) Verwendung von Zink-Calciumhydroxid, Lecithin und PAO zur Adjuvierung von Antigenlösungen und auf diese Weise adjuvierte Antigenlösungen

Legal Events

Date Code Title Description
OP8 Request for examination as to paragraph 44 patent law
8128 New person/name/address of the agent

Representative=s name: LEDERER, F., DIPL.-CHEM. DR., PAT.-ANW., 8000 MUEN

D2 Grant after examination
8364 No opposition during term of opposition